On February 17, AI medical concept stocks continued to be hot in the capital market. Meinian Health has 5 boards in 7 days, Anping has 20CM for two consecutive days, Saili Medical has 5 boards in 10 days, Jiahe Meikang, Xin Ganjiang, Sichuang Yihui, and Chaoyan shares have risen by more than 10%.

Some popular concept stocks have also successively issued announcements on abnormal stock trading fluctuations. For example, Meinian Health announced on February 16 that the company's current business situation is normal, and there has been no major changes in the internal and external business environment. After verification, the company and the actual controller have no major matters that should be disclosed but have not been disclosed or major matters in the planning stage.

Anping issued an announcement on February 17, saying that the company has recently noticed that many media reported that Huawei Technologies Co., Ltd. will build a Ruijin pathology model based on Huawei DCS AI solution, which is scheduled to be officially released on February 18, 2025. The company clarified the relevant matters as follows: The company did not participate in the research and development of the Ruijin pathology model. In May 2022, the company signed the "Memorandum of Understanding for Histological Pathology Diagnosis Based on Ascend AI Hardware Platform" with Huawei Technologies Co., Ltd. The cooperation intention includes exploring native trusted AI and explainable AI technologies for pathology images. As of the date of disclosure of this announcement, the cooperation between the two parties has not formed a specific product.

https://finance.eastmoney.com/a/202502183321598760.html